Validity of composite end points in clinical trials

Victor M. Montori; Gaietà Permanyer-Miralda; Ignacio Ferreira-González; Jason W. Busse; Valeria Pacheco-Huergo; Dianne Bryant; Jordi Alonso; Elie A. Akl; Antònia Domingo-Salvany; Edward Mills; Ping Wu; Holger J. Schünemann; Roman Jaeschke; Gordon H. Guyatt

doi:10.1136/bmj.330.7491.594

Validity of composite end points in clinical trials

Victor M. Montori, Gaietà Permanyer-Miralda, Ignacio Ferreira-González, Jason W. Busse, Valeria Pacheco-Huergo, Dianne Bryant, Jordi Alonso, Elie A. Akl, Antònia Domingo-Salvany, Edward Mills, Ping Wu, Holger J. Schünemann, Roman Jaeschke, Gordon H. Guyatt

Research output: Contribution to journal › Review article › peer-review

283 Scopus citations

Abstract

Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?

Original language	English (US)
Pages (from-to)	594-596
Number of pages	3
Journal	British medical journal
Volume	330
Issue number	7491
DOIs	https://doi.org/10.1136/bmj.330.7491.594
State	Published - Mar 12 2005

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmj.330.7491.594

Cite this

@article{5de99490ee5741af8d7c7d886f53e965,

title = "Validity of composite end points in clinical trials",

abstract = "Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?",

author = "Montori, {Victor M.} and Gaiet{\`a} Permanyer-Miralda and Ignacio Ferreira-Gonz{\'a}lez and Busse, {Jason W.} and Valeria Pacheco-Huergo and Dianne Bryant and Jordi Alonso and Akl, {Elie A.} and Ant{\`o}nia Domingo-Salvany and Edward Mills and Ping Wu and Sch{\"u}nemann, {Holger J.} and Roman Jaeschke and Guyatt, {Gordon H.}",

year = "2005",

month = mar,

day = "12",

doi = "10.1136/bmj.330.7491.594",

language = "English (US)",

volume = "330",

pages = "594--596",

journal = "British medical journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7491",

}

TY - JOUR

T1 - Validity of composite end points in clinical trials

AU - Montori, Victor M.

AU - Permanyer-Miralda, Gaietà

AU - Ferreira-González, Ignacio

AU - Busse, Jason W.

AU - Pacheco-Huergo, Valeria

AU - Bryant, Dianne

AU - Alonso, Jordi

AU - Akl, Elie A.

AU - Domingo-Salvany, Antònia

AU - Mills, Edward

AU - Wu, Ping

AU - Schünemann, Holger J.

AU - Jaeschke, Roman

AU - Guyatt, Gordon H.

PY - 2005/3/12

Y1 - 2005/3/12

N2 - Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?

AB - Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?

UR - http://www.scopus.com/inward/record.url?scp=20144373791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144373791&partnerID=8YFLogxK

U2 - 10.1136/bmj.330.7491.594

DO - 10.1136/bmj.330.7491.594

M3 - Review article

C2 - 15761002

AN - SCOPUS:20144373791

SN - 0959-8146

VL - 330

SP - 594

EP - 596

JO - British medical journal

JF - British medical journal

IS - 7491

ER -

Validity of composite end points in clinical trials

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this